Concepedia

Mark Wei Yi Tan

MW

Statistics

Publications

3

Citations

63

H-Index

3

Active since

2020

Affiliations

Nanyang Technological University(Current)

Agency for Science, Technology and Research

University College London

Institute of Molecular and Cell Biology

Singapore Eye Research Institute

Mark Wei Yi Tan is an author at Nanyang Technological University specializing in molecular oncology, signal transduction, and oncology.

ORCID

Publications per year

2020–2023

3

Publications

3

Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma

Caroline E. Gleason, Mark A. Dickson, Mary E. Klein et al. · Clinical Cancer Research · 2023 · 34 citations · Full text

, , +17

High Glucose Restraint of Acetylcholine-Induced Keratinocyte Epithelial-Mesenchymal Transition Is Mitigated by p38 Inhibition

Mark Wei Yi Tan, Wei Tan, Ze Qing Kong et al. · Journal of Investigative Dermatology · 2020 · 16 citations · Full text

, , +9

Deficiency in fibroblast PPARβ/δ reduces nonmelanoma skin cancers in mice

Mark Wei Yi Tan, Ming Keat Sng, Hong Sheng Cheng et al. · Cell Death and Differentiation · 2020 · 13 citations · Full text

, , +14

1–3 of 3